Related references
Note: Only part of the references are listed.The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
Saori Oka et al.
JOURNAL OF BIOCHEMISTRY (2009)
The Endogenous Brain Constituent N-Arachidonoyl L-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels
Grzegorz Godlewski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
P. Pacher et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
Markus Waldeck-Weiermair et al.
JOURNAL OF CELL SCIENCE (2008)
Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF
Xiao-Yong Man et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
N-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca2+ channels in sympathetic neurons
Juan Guo et al.
JOURNAL OF NEUROPHYSIOLOGY (2008)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Mauro Maccarrone et al.
NATURE NEUROSCIENCE (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids:: Evidence for a site distinct from CB1 and CB2
Douglas McHugh et al.
MOLECULAR PHARMACOLOGY (2008)
Novel cannabinoid receptors
A. J. Brown
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Endocannabinoids and the haematological system
M. D. Randall
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The endocannabinoid system in the regulation of cardiometabolic risk factors
Luigi Bellocchio et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
Ronen Durst et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Identification of GPR55 as a lysophosphatidylinositol receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Science and society - Cannabis, the mind and society: the hash realities
Robin M. Murray et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells
Christiane A. Opitz et al.
FEBS LETTERS (2007)
Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation
Xuefeng Zhang et al.
CANCER RESEARCH (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Molecular regulation of angiogenesis and lymphangiogenesis
Ralf H. Adams et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Hardwiring the brain:: Endocannabinoids shape neuronal connectivity
Paul Berghuis et al.
SCIENCE (2007)
Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy
Simona Pisanti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Signaling pathways involved in the cardioprotective effects of cannabinoids
Philippe Lepicier et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties
G Milman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
In silico patent searching reveals a new cannabinoid receptor
D Baker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Evidence for novel cannabinoid receptors
M Begg et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Endocannabinoid control of food intake and energy balance
V Di Marzo et al.
NATURE NEUROSCIENCE (2005)
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1
FM Mo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism
N Pore et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation
HB Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current
M Begg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor
L Offertáler et al.
MOLECULAR PHARMACOLOGY (2003)
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts
M Joyeux et al.
CARDIOVASCULAR RESEARCH (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
AC Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Stimulation of β1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration
JF Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Human brain capillary endothelium - 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1
Y Chen et al.
CIRCULATION RESEARCH (2000)
MAP kinases and hypoxia in the control of VEGF expression
E Berra et al.
CANCER AND METASTASIS REVIEWS (2000)
Share Paper
